4 reports

It is also developing new approaches to the treatment of asthma.

  • Influenza Antiviral
  • Pharmaceutical
  • United States
  • World
  • Product Initiative

The institute' s research areas include infectious diseases such as tuberculosis and influenza, HIV/ AIDS, biodefense; and immune-mediated diseases including asthma and allergy.

  • Influenza Antiviral
  • Israel
  • United States
  • Company
  • BiondVax Pharmaceuticals Ltd.

The estimated cost of the Phase II trial is under $## million.

  • Influenza Antiviral
  • Pharmaceutical
  • Therapy
  • United States
  • Can-Fite BioPharma Ltd.

OCT ##, 2017: BIOCRYST ANNOUNCES LATE BREAKER PRESENTATION OF BCX## PHASE ## APEX-## TRIAL RESULTS AT THE ACAAI' S 2017 ANNUAL SCIENTIFIC MEETING BioCryst Pharmaceuticals, Inc., announced that results from its successful Phase ## APeX-## clinical trial in hereditary angioedema (H

  • Influenza Antiviral
  • Pharmaceutical
  • Therapy
  • United States
  • BioCryst Pharmaceuticals, Inc.